Sign In
Buy PTC
$139.72
-2.62 (-1.84%)
At Close: Jun 03, 2026
Industrial software maker PTC trims annual forecast amid tariff concerns
05:34pm, Wednesday, 05'th Feb 2025
PTC cut its full-year revenue and adjusted earnings forecasts on Wednesday amid increasing competition and fears over President Donald Trump's tariff policy, which could result in fewer takers for its
PTC ANNOUNCES FIRST FISCAL QUARTER 2025 RESULTS
04:01pm, Wednesday, 05'th Feb 2025
Solid ARR and Cash Flow BOSTON , Feb. 5, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today reported financial results for its first fiscal quarter ended December 31, 2024. "In Q1'25, we delivered solid ye
Countdown to PTC Inc. (PTC) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
10:20am, Tuesday, 04'th Feb 2025
Get a deeper insight into the potential performance of PTC Inc. (PTC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for s
PTC to Report Q1 Earnings: Here's What Investors Should Know
09:45am, Monday, 03'rd Feb 2025
PTC's fiscal first-quarter performance is likely to have been driven by demand for PLM and CAD in a tough selling environment and go-to-market realignment.
CoreSite to be Featured at PTC 2025
11:00am, Thursday, 16'th Jan 2025
DENVER--(BUSINESS WIRE)--CoreSite, a leading hybrid IT solutions provider and subsidiary of American Tower Corporation (NYSE: AMT) (“American Tower”), will participate in the upcoming Pacific Tele
PTC to Announce Fiscal Q1'25 Results on Wednesday, February 5th, 2025
09:49am, Wednesday, 15'th Jan 2025
BOSTON , Jan. 15, 2025 /PRNewswire/ -- PTC (Nasdaq: PTC) will release its fiscal 2025 first quarter results on Wednesday, February 5 th after the stock market closes. Senior management will host a li
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Monday, 13'th Jan 2025
WARREN, N.J. , Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 3, 2025, the company approved 1,200 restricted stock units ("RSUs"), each representing
PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference
09:00am, Monday, 13'th Jan 2025
– Unaudited 2024 total revenue of approximately $814 million, exceeding guidance – – Four approval applications submitted to FDA in 2024 – – Global launch preparations underway for sepiapter
PTC Faces Markets And Sales Motion Uncertainties (Downgrade)
03:14pm, Monday, 06'th Jan 2025
PTC reported better-than-expected FQ4 2024 results, but faces challenges in top line revenue growth due to macro headwinds and go-to-market changes. The global PLM market is projected to grow at a 9.2
PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08:00am, Monday, 23'rd Dec 2024
WARREN, N.J. , Dec. 23, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B.
This Software Stock Could Be the Best Investment of the Decade
04:54am, Saturday, 21'st Dec 2024
Every consumer knows about the growing role of artificial intelligence (AI) and wirelessly enabled digital technologies in our daily lives. But not everyone knows about the seismic shift these develop
PTC Therapeutics Announces Vatiquinone NDA Submission to FDA for the Treatment of Children and Adults Living with Friedreich Ataxia
08:00am, Thursday, 19'th Dec 2024
- If approved, vatiquinone would be the first and only authorized therapy for children with FA - - PTC's fourth approval application submitted to FDA in 2024 - WARREN, N.J. , Dec. 19, 2024 /PRNewswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Tuesday, 17'th Dec 2024
WARREN, N.J. , Dec. 17, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Dec. 13, 2024, the company approved non-statutory stock options to purchase an aggregate of 1
PTC Appoints Robert Dahdah as Executive Vice President, Chief Revenue Officer
08:30am, Monday, 09'th Dec 2024
BOSTON , Dec. 9, 2024 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it has appointed Robert Dahdah as Executive Vice President, Chief Revenue Officer. Dahdah joins PTC from Microsoft, where
Why Is PTC Inc. (PTC) Up 5.7% Since Last Earnings Report?
06:48am, Monday, 09'th Dec 2024
PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock?
